Skip to content

Redente Laboratory

The Redente laboratory focuses on the development and resolution of pulmonary fibrosis. We use cutting edge genetic mouse models and clinical samples to answer or questions. Our questions right now are focused on: 1) Fibroblast persistence and the role of Bcl-2 induced apoptosis in the resolution of established pulmonary fibrosis with the goal to investigate the mechanisms by which inducing to apoptosis can act as the basis for translational application of this work. 2) The role of collagen degradation during fibrosis resolution through the matrix metalloproteinase MMP-9. 3) The role of macrophage lipid mishandling as an initiator of lung injury and pulmonary fibrosis and 4) In collaboration with investigators at National Jewish and the University of Colorado we are investigating the role of Muc5B mis-expression and how this leads to altered epithelial cell and fibroblast communication to drive pulmonary fibrosis. 

We seek to complete this research in an inclusive, supportive and positive work and training environment. Fantastic science is our goal and we can get there through collaboration and thinking outside the box!


Lab Resources and Services

Dr. Redente’s laboratory is located in Smith building on National Jewish Health’s campus and offers several unique research methods and animal models for pulmonary basic science and translational research. 


Current research projects and grant support

Elizabeth F. Redente

Elizabeth F. Redente, PhD

Personnel

  • Principal Investigator
    Elizabeth F. Redente, PhD
  • Lab Members
    Cody Schott, MD, PhD
    Ben Edelman, BA
    Nomin Javkhlan, BS, MS
    Jasmine Wilson, BA


Collaborators

Publications

  1. Bamberg A*, Redente EF*, Groshong SD, Tuder RM, Cool CD, Keith RC, Edelman BL, Black BP, Cosgrove GP, Wynes MW, Curran-Everett D, De Lang S, Ortiz LA, Thorburn A, Grusby MJ, Riches DWH. The protein tyrosine phosphatase PTPN13 links lung fibroblast resistance to apoptosis with the development of pulmonary fibrosis. Am J Respir and Crit Care Med. 2018. Oct 1;198(7):914-927. PMID: 29727583
  1. Redente EF, Chakraborty S, Sajuthi S, Black BP, Edelman BL, Seibold MA, et al. Loss of Fas-signaling in fibroblasts impairs homeostatic fibrosis resolution and promotes persistent pulmonary fibrosis. JCI Insight. 2020. Dec 8;6(1):e14161. PMID: 33290280

More Publications